Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to 0.60%.

  • Rockwell Medical's EBITDA Margin fell 1678.00% to -9.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.37%, marking a year-over-year decrease of 695.00%. This contributed to the annual value of 0.60% for FY2024, which is 858.00% up from last year.
  • As of FY2024, Rockwell Medical's EBITDA Margin stood at 0.60%, which was up 107.51% from -7.98% recorded in FY2023.
  • Rockwell Medical's 5-year EBITDA Margin high stood at 0.60% for FY2024, and its period low was -48.98% during FY2021.
  • Its 3-year average for EBITDA Margin is -10.14%, with a median of -7.98% in 2023.
  • Per our database at Business Quant, Rockwell Medical's EBITDA Margin crashed by 329bps in 2021 and then spiked by 2,594bps in 2022.
  • Rockwell Medical's EBITDA Margin (Yearly) stood at -45.69% in 2020, then crashed by 329bps to -48.98% in 2021, then surged by 2,594bps to -23.05% in 2022, then spiked by 1,507bps to -7.98% in 2023, then surged by 858bps to 0.60% in 2024.